Type / Class
Equity / Common Stock, par value $0.001 per share (the "Shares")
Shares outstanding
93.8M
Number of holders
106
Total 13F shares, excl. options
50.5M
Shares change
+5.21M
Total reported value, excl. options
$941M
Value change
+$94M
Number of buys
58
Number of sells
-44
Price
$18.65

Significant Holders of Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX) as of Q2 2022

124 filings reported holding CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") as of Q2 2022.
Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 50.5M shares of 93.8M outstanding shares and own 53.85% of the company stock.
Largest 10 shareholders include DRIEHAUS CAPITAL MANAGEMENT LLC (5.47M shares), PERCEPTIVE ADVISORS LLC (5.32M shares), BlackRock Inc. (3.79M shares), BVF INC/IL (3.68M shares), ORBIMED ADVISORS LLC (3.2M shares), FMR LLC (2.99M shares), VANGUARD GROUP INC (2.44M shares), Bain Capital Life Sciences Investors, LLC (2.31M shares), WELLINGTON MANAGEMENT GROUP LLP (1.82M shares), and STATE STREET CORP (1.76M shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.